Biosensor prototype for rapid detection and quantification of DNase activity.

Biosens Bioelectron

Life Sciences Center, Vilnius University, Saulėtekio al. 7, LT-10257, Vilnius, Lithuania; UAB "Bioanalizės sistemos", Saulėtekio al. 15, LT-10224, Vilnius, Lithuania. Electronic address:

Published: October 2022

DNases are enzymes that cleave phosphodiesteric bonds of deoxyribonucleic acid molecules and are found everywhere in nature, especially in bodily fluids, i.e., saliva, blood, or sweat. Rapid and sensitive detection of DNase activity is highly important for quality control in the pharmaceutical and biotechnology industries. For clinical diagnostics, recent reports indicate that increased DNase activity could be related to various diseases, such as cancers. In this paper, we report a new bioelectronic device for the determination of nuclease activity in various fluids. The system consists of a sensor electrode, a custom design DNA target to maximize the DNase cleavage rate, a signal analysis algorithm, and supporting electronics. The developed sensor enables the determination of DNase activity in the range of 3.4 × 10 - 3.0 × 10 U mL with a limit of detection of up to 3.4 × 10 U mL. The sensor was tested by measuring nuclease activity in real human saliva samples and found to demonstrate high accuracy and reproducibility compared to the industry standard DNaseAlert™️. Finally, the entire detection system was implemented as a prototype device system utilizing single-use electrodes, custom-made cells, and electronics. The developed technology can improve nuclease quality control processes in the pharmaceutical/biotechnology industry and provide new insights into the importance of nucleases for medical applications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bios.2022.114475DOI Listing

Publication Analysis

Top Keywords

dnase activity
16
quality control
8
nuclease activity
8
electronics developed
8
activity
6
dnase
5
biosensor prototype
4
prototype rapid
4
detection
4
rapid detection
4

Similar Publications

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Penn Neurodegeneration Genomics Center, Dept of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Background: Recent Alzheimer's disease (AD) genome-wide association studies () have identified >75 risk loci, with >98% of genome-wide significant variants residing in non-coding genomic regions, making it more difficult to infer their functional contexts. In this study, we aim to jointly 1) fine-map causal loci/variants, and 2) identify affected cell types and functional elements by interrogating large-scale collections of thousands of heterogenous, cell type-specific functional genomic (FG) datasets.

Method: We analyzed the full genome-wide summary statistics (n = 21,101,114 variants) from the recent AD GWAS (Bellenguez et al, 2022) (Ncases = 111,326, Ncontrols = 677,663).

View Article and Find Full Text PDF

Introduction: Pleural infections are a significant cause of mortality. Intrapleural fibrinolytic therapy (IPFT) utilising alteplase and dornase is a treatment option for patients unsuitable for surgery. The optimal dose of alteplase is unknown, and factors affecting treatment success in an Asian population are unclear.

View Article and Find Full Text PDF

Genomic analysis of isolated from surface water and animal sources in Chile reveals new T6SS effector protein candidates.

Front Microbiol

December 2024

Núcleo de Investigación en One Health, Facultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas, Santiago, Chile.

Type VI Secretion Systems (T6SS), widely distributed in Gram-negative bacteria, contribute to interbacterial competition and pathogenesis through the translocation of effector proteins to target cells. harbor 5 pathogenicity islands encoding T6SS (SPI-6, SPI-19, SPI-20, SPI-21 and SPI-22), in which a limited number of effector proteins have been identified. Previous analyses by our group focused on the identification of candidate T6SS effectors and cognate immunity proteins in genomes deposited in public databases.

View Article and Find Full Text PDF

Intranasal administration of angiotensin receptor shRNA to brain lowers blood pressure in spontaneously hypertensive rats.

Biomed Pharmacother

December 2024

Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58102, United States. Electronic address:

Neurogenic hypertension (NH) is characterized by heightened sympathetic activity mediated by angiotensin II in specific brain areas including the paraventricular nucleus and circumventricular organs. While strategies targeting sympathetic activity have shown effectiveness in managing NH, their invasive nature hinders their widespread clinical adoption. Conversely, nose-to-brain drug delivery is emerging as a promising approach to access the brain with reduced invasiveness.

View Article and Find Full Text PDF

CRISPR technology combined with isothermal amplification methods for the diagnosis of Candida albicans infection.

Clin Chim Acta

December 2024

Department of Clinical Laboratory, the First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China; Department of Clinical Laboratory, Anhui Public Health Clinical Center, Hefei, People's Republic of China. Electronic address:

Since Candida albicans, a type of fungus, causes severe infections that pose a significant threat to human health, its rapid detection is critical in clinical antifungal therapy. Traditional fungal diagnostic approaches are largely based on the culture method. This method is time-consuming and laborious, taking about 48-72 h, and cannot identify emerging species, making it unsuitable for critically ill patients with bloodstream infections, sepsis, and so on.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!